Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesLong-Term Debt RepaymentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares Outstanding
Ratios

NovaBay Pharmaceuticals (NBY) Amortization - Deferred Charges (2023 - 2024)

Historic Amortization - Deferred Charges for NovaBay Pharmaceuticals (NBY) over the last 2 years, with Q4 2024 value amounting to $33000.0.

  • NovaBay Pharmaceuticals' Amortization - Deferred Charges fell 9386.62% to $33000.0 in Q4 2024 from the same period last year, while for Sep 2025 it was $471000.0, marking a year-over-year decrease of 6657.2%. This contributed to the annual value of $904000.0 for FY2024, which is 4663.52% down from last year.
  • Latest data reveals that NovaBay Pharmaceuticals reported Amortization - Deferred Charges of $33000.0 as of Q4 2024, which was down 9386.62% from $138000.0 recorded in Q3 2024.
  • In the past 5 years, NovaBay Pharmaceuticals' Amortization - Deferred Charges registered a high of $655000.0 during Q3 2023, and its lowest value of $33000.0 during Q4 2024.